1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ACLARIS THERAPEUTICS INC
Aclaris Therapeutics Inc
XNAS: ACRS
3.98 0.05 (1.27%)
1.1M
XNAS Volume

XNAS 16 Apr, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Aclaris Therapeutics Inc - ACRS - stock price prediction, stock price target, analyst ratings from 8 analysts

Aclaris Therapeutics Inc has a share price target of US$ 8, revenue growth forecast of -42.3%, and profit growth estimate of -15.6% for FY26, based on top 8 analyst calls.